Iron-chelating and free-radical scavenging activities of microwave-processed green tea in iron overload

Hemoglobin

Volumn 30, Issue 2, 2006, Pages 311-327

  Srichairatanakool, Somdet ^a   Ounjaijean, Sakaewan ^a   Thephinlap, Chonthida ^a   Khansuwan, Udompun ^a   Phisalpong, Chada ^b   Fucharoen, Suthat ^c  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b Thailand Government Pharmaceutical Organization   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Green tea (GT); Non transferrin bound iron (NTBI); Oxidative stress

Indexed keywords

ANTIOXIDANT; CATECHIN; DEFERIPRONE; DEFEROXAMINE; EDETATE IRON; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FERRIC ION; FREE RADICAL; IRON; NATURAL PRODUCT; POLYPHENOL DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFERRIN;

ANTIOXIDANT ACTIVITY; BETA THALASSEMIA; BLOOD TRANSFUSION; COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; ERYTHROCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IRON ABSORPTION; IRON CHELATION; IRON OVERLOAD; LIPID PEROXIDATION; MICROWAVE RADIATION; OXIDATIVE STRESS; PLASMA; TEA; VENOUS BLOOD;

ANTIOXIDANTS; BETA-THALASSEMIA; CAMELLIA SINENSIS; CATECHIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESICCATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ERYTHROCYTES; FERRIC COMPOUNDS; FREE RADICAL SCAVENGERS; HEAT; HUMANS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; KINETICS; LIPID PEROXIDATION; MICROWAVES; NITRATES; OXIDATIVE STRESS; PLANT EXTRACTS; PLASMA; TEA;

EID: 33745519058     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260600642666     Document Type: Conference Paper

References (47)

1. Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassemias. Nat Rev Genet 2001; 2(4):245-255.
2. Olivieri NF. The β-thalassemias. N Engl J Med 1999; 341 (2):99-109.
3. Prasartkaew S, Bunyaratvej A, Fucharoen S, Wasi P. Oxidative stress and antioxidative enzymes in Hemoglobin H disease. Birth Defects Orig Artic Ser 1987; 23(5A):193-198.
4. Suthipark K, Ong-ajyooth S, Shumnumsirivath D, Likidlilid A, Fucharoen S, Siddhikol C, Pootrakul P, Niyomporn B. Oxidative stress and antioxidants in β-thalassemia/Hemoglobin E. Birth Defects Orig Artic Ser 1987; 23(5A):199-205.
5. Kattamis C, Kattamis AC. Oxidative stress disturbances in erythrocytes of β-thalassemia. Pediatr Hematol Oncol 2001; 18(2):85-88.
6. Cighetti G, Duca L, Bortone L, Sala S, Nava I, Fiorelli G, Cappellini MD. Oxidative status and malondialdehyde in β-thalassaemia patients. Eur J Clin Invest 2002; 32(Suppl 1):55-60.
7. Amer J, Fibach E. Oxidative status of platelets in normal and thalassemic blood. Thromb Haemost 2004; 92(5):1052-1059.
8. Amer J, Fibach E. Chronic oxidative stress reduces the respiratory burst response of neutrophils from β-thalassaemia patients. Br J Haematol 2005; 129(3):435-441.
9. Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben HJ, D'Arpa D, D'Anna R, Bongiorno A. Oxidative stress and antioxidant status in β-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996; 88(9):3608-3614.
10. De Luca C, Filosa A, Grandinetti M, Maggio F, Lamba M, Passi S. Blood antioxidant status and urinary levels of catecholamine metabolites in β-thalassemia. Free Radic Res 1999; 30(6):453-462.
11. Meral A, Tuncel P, Surmen-Gur E, Ozbek R, Ozturk E, Gunay U. Lipid peroxidation and antioxidant status in β-thalassemia. Pediatr Hematol Oncol 2000; 17(8):687-693.
12. Chakraborty D, Bhattacharyya M. Antioxidant defense status of red blood cells of patients with β-thalassemia and Eβ-thalassemia. Clin Chim Acta 2001; 305(1-2):123-129.
13. Kassab-Chekir A, Laradi S, Ferchichi S, Haj Khelil A, Feki M, Amri F, Selmi H, Bejaoui M, Miled A. Oxidant, antioxidant status and metabolic data in patients with β-thalassemia. Clin Chim Acta 2003; 338(1-2):79-86.
14. Graham G, Bates GW, Rachmilewitz KA, Hershko C. Nonspecific serum iron in thalassemia: quantitation and chemical reactivity. Am J Hematol 1979; 6(3):207-217.
15. Ahmed NK, Hanna M, Wang W. Nontransferrin-bound serum iron in thalassemia and sickle cell patients. Int J Biochem 1986; 18(10):953-956.
16. Breuer W, Ermers MJ, Pootrakul P, Abramov A, Hershko C, Cabantchik ZI. Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood 2001; 97(3):792-798.
17. Pootrakul P, Breuer W, Sametband M, Sirankapracha P, Hershko C, Cabantchik ZI. Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded β-thalassemia/HbE patients treated with an oral chelator. Blood 2004; 104(5):1504-1510.
18. Gutteridge JM, Rowley DA, Griffiths E, Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci (Lond) 1985; 68(4):463-476.
19. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341(26):1986-1995.
20. Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol 2005; 18(2):277-287.
21. Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematology (Am Soc Hematol Educ Program) 2001; 47-61.
22. Olivieri NF, Brittenham GM. Iron-chelating therapy and treatment of thalassemia. Blood 1997; 89(3):739-761.
23. Porter JB. A risk-benefit assessment of iron-chelation therapy. Drug Saf 1997; 17(6):407-421.
24. al-Refaie FN, Wickens DG, Wonke B, Kontoghiorghes GJ, Hoffbrand AV. Serum non-transferrin-bound iron in β-thalassaemia major patients treated with desferrioxamine and L1. Br J Haematol 1992; 82(2):431-436.
25. Schrier SL, Angelucci E. New strategies in the treatment of the thalassemias. Annu Rev Med 2005; 56:157-171.
26. Zhang A, Zhu QY, Luk YS, Ho KY, Fung KP, Chen ZY. Inhibitory effects of jasmine green tea epicatechin isomers on free radical-induced lysis of red blood cells. Life Sci 1997; 61(4):383-394.
27. Samman S, Sandstrom B, Toft MB, Bukhave K, Jensen M, Sorensen SS, Hansen M. Green tea or rosemary extract added to foods reduces nonheme-iron absorption. Am J Clin Nutr 2001; 73(3):607-612.
28. Hamdaoui M, Hedhili A, Doghri T, Tritar B. Effect of tea on iron absorption from the typical Tunisian meal 'couscous' fed to healthy rats. Ann Nutr Metab 1994; 38(4):226-231.
29. de Alarcon PA, Donovan ME, Forbes GB, Landaw SA, Stockman JA 3rd. Iron absorption in the thalassemia syndromes and its inhibition by tea. N Engl J Med 1979; 300(1):5-8.
30. Pillai SP, Mitscher LA, Menon SR, Pillai CA, Shankel DM. Antimutagenic/antioxidant activity of green tea components and related compounds. J Environ Pathol Toxicol Oncol 1999; 18(3):147-158.
31. Lopes GKB, Schulman HM, Hermes-Lima M. Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous iron. Biochim Biophys Acta 1999; 1472(1-2):142-152.
32. Guo Q, Zhao B, Li M, Shen S, Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim Biophys Acta 1996; 1304(3):210-222.
33. Grinberg LN, Newmark H, Kitrossky N, Rahamim E, Chevion M, Rachmilewitz EA. Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharmacol 1997; 54(9):973-978.
34. Chen Z, Zhu QY, Tsang D, Huang Y. Degradation of green tea catechins in tea drinks. J Agric Food Chem 2001; 49(1):477-482.
35. van den Berg R, Haenen GRMM, van der Berg H, Bast A. Applicability of an improved Trolox equivalent antioxidant capacity (TEAC) assay for evaluation of antioxidant capacity measurements of mixtures. Food Chem 1999; 66:391-395.
36. Sigh S, Hider RC, Porter JB. A direct method for quantification of non-transferrin bound iron. Anal Biochem 1990; 186(2):320-323.
37. Chiroco S. High-performance liquid chromatography-based thiobarbituric acid test. Methods Enzymol 1994; 233:314-318.
38. Amer J, Goldfarb A, Fibach E. Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry A 2004;60(1):73-80.
39. Gulati A, Rawat R, Singh B, Ravindranath SD. Application of microwave energy in the manufacture of enhanced-quality green tea. J Agric Food Chem 2003; 51(16):4764-4768.
40. Ackrill P, Day JP. Desferrioxamine in the treatment of aluminium overload. Clin Nephrol 1985; 24(Suppl 1):S94-S97.
41. Salah N, Miller NJ, Paganga G, Tijberg L, Bothwell GP, Rice-Evans C. Polyphenolic flavonols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 1995; 322(2):339-346.
42. Brune M, Rossander L, Hallberg L. Iron absorption and phenolic compounds: importance of different phenolic structures. Eur J Clin Nutr 1989; 43(8):547-557.
43. Heim KE, Tagliaferro AR, Bobilya DJ. Flavoinoid antioxidants: chemistry, metabolism and structure activity relationships. J Nutr Biochem 2002; 13(10):572-584.
44. Mochizuki M, Yamazaki H, Kano K, Ikeda T. Kinetic analysis and mechanistic aspects of autoxidation of catechins. Biochim Biophys Acta 2002; 1569(1-3):35-44.
45. Hider RC, Liu ZD, Khodr HH. Metal chelation of polyphenols. Methods Enzymol 2001; 335:190-203.
46. Hider RC. Nature of nontransferrin-bound iron. Eur J Clin Invest 2002; 32(Suppl 1):50-54.
47. Cheviom M. Protection against free-radical-induced and transition-mediated damage: the use of "pull" and "push" mechanisms. Free Radic Res Commun 1991; 12-13(Pt 2):691-696.